US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
(This July 6 story has been corrected to fix the court where filing was made...
By Jody Godoy (Reuters) -Twitter has threatened to sue Meta Platforms over its new Threads...
By Lewis Krauskopf, Bansari Mayur Kamdar and Johann M Cherian (Reuters) – Wall Street’s main...
By Andrea Shalal and Yew Lun Tian BEIJING (Reuters) -U.S. Treasury Secretary Janet Yellen on...
By Martin Coulter (Reuters) -Meta Platforms plans to launch a Twitter-rivalling microblogging app called Threads,...
WASHINGTON (Reuters) – The Pentagon holds a strategic U.S. stockpile for germanium but currently has...
A look at the day ahead in U.S. and global markets from Mike Dolan World...
By Kanishka Singh WASHINGTON (Reuters) -A U.S. federal judge on Tuesday restricted some agencies and...
NEW YORK (Reuters) – Bank of America (BofA) said on Wednesday it planned to increase...